Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2026-02-22 @ 3:56 PM
Study NCT ID:
NCT03308968
Status:
COMPLETED
Last Update Posted:
2021-11-09
First Post:
2017-10-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-03
First Submit QC Date:
None
Study First Post Date:
2017-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-09-19
Results First Submit QC Date:
None
Results First Post Date:
2019-10-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-05
Last Update Post Date:
2021-11-09
Last Update Post Date Type:
ACTUAL